News

CUTISS Announces First Reconstructive Surgery under Compassionate Use and First U.S. Patient Treated with denovoSkin™

Boston, MA and Switzerland, 10 October 2024 – CUTISS AG, a life sciences company at the forefront of tissue engineering therapy and regenerative medicine, announced the first ever grafting of denovoSkin™, its autologous, bio-engineered dermo-epidermal skin graft, in a compassionate reconstructive procedure, with the patient also being the first ever U.S....

read more

LIFE SCIENCE ZURICH IMPACT CONFERENCE

On Monday, May 26th, 2025, at the Technopark Zurich, the fourth Life Science Zurich Impact Conference will take place. This time it’s all about «Precision Medicine and AI Innovations». Save the date or register already today! After three very successful LSZ Impact conferences in 2018, 2020 and 2023 the fourth event will...

read more